Global Systemic Psoriasis Therapeutics Market Worth $ 13.6 Billion by 2020

Date: 2017-08-24

Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.There is no cure for psoriasis. However, various treatments can help control the symptoms. Systemic Psoriasis Therapeutics includes External medication, Medicine for oral administration and Ultraviolet therapy on the base of classification, which represent 33%, 30% and 16% of global Systemic Psoriasis Therapeutics market. 

Psoriasis treatment and Other skin disease are the main application of Systemic Psoriasis Therapeutics product and North American is the largest Systemic Psoriasis Therapeutics market on production and consumption.

Global Systemic Psoriasis Therapeutics market is projected to reach $ 13.6 Billion by 2020, with a GAGR of 7.4% from 2016, and Asia will have a big dynamic momentum on the market growth. The major players in the global Systemic Psoriasis Therapeutics market are AbbVie, Biogen, Celgene, Pfizer, Amgen, Janssen, Stiefel, Novartis, Almirall, Xian Janssen, VBL Therapeutics, Sun Pharmaceutical etc.

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample